drug · small molecule
patient view →bupivacaine
Marketedupdated 2mo agoby Allay Therapeutics Inc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for pain and hernia and 77 investigational indications.
targets
Sodium channel protein type 4 subunit alpha
all catalysts(14)
phase 1 2 completion · 2
phase 1 completion · 2
phase 2 completion · 6
phase 2 initiation · 3
phase 3 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that